Sharonit Sahar-Helft

All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.

Open AccessArticle by Sharonit Sahar-Helft 1,2, Nathanyel Sebbane 1,3,4, Adi Farber 1,3, Ronit Vogt Sionov 3, Roni Dakar 2 and Doron Steinberg 3,* 1 Department of Endodontics, The Faculty of Dental Medicine, The Hebrew University-Hadassah, 9112102 Jerusalem, Israel 2 Endodontics Department, School of Graduate Dentistry, Rambam Health Care Campus, The Ruth and Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, 3200003 Haifa, Israel 3 Biofilm Research Laboratory, The...

In recent years, there have been dramatic changes in anti-thrombotic treatment as a result of new anti-thrombotic agents, as well as changes in the indications for their use. As a consequence, dentists are encountering larger numbers of patients who are undergoing anti-thrombotic treatment and who have increased risk for bleeding. The current paper aims to review the literature regarding up-to-date anti-thrombotic treatment and provide information regarding their implications on dentistry.